Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Acelrx Pharmaceuticals (ACRX)
NASDAQ:ACRX
Acelrx (ACRX) Stock Price & Analysis
1,861 Followers
ACRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.57 - $7.61
Previous Close$0.69
Volume59.85K
Average Volume (3M)240.93K
Market Cap
$6.28M
Enterprise Value$3.08M
Total Cash (Recent Filing)$15.93M
Total Debt (Recent Filing)$12.47M
Price to Earnings (P/E)0.1
Beta-0.04
Next Earnings
Mar 30, 2023EPS Estimate
-$10.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.23
Shares Outstanding8,198,110
10 Day Avg. Volume569,305
30 Day Avg. Volume240,929
Standard Deviation0.21
R-Squared0.00477
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.31
Price to Sales (P/S)3.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.02
Enterprise Value/Gross Profit-3.29
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Acelrx News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACRX FAQ
What was Acelrx Pharmaceuticals’s price range in the past 12 months?
Acelrx Pharmaceuticals lowest stock price was $0.57 and its highest was $7.61 in the past 12 months.
What is Acelrx Pharmaceuticals’s market cap?
Currently, no data Available
When is Acelrx Pharmaceuticals’s upcoming earnings report date?
Acelrx Pharmaceuticals’s upcoming earnings report date is Mar 30, 2023 which is tomorrow.
How were Acelrx Pharmaceuticals’s earnings last quarter?
Acelrx Pharmaceuticals released its earnings results on Nov 14, 2022. The company reported -$0.94 earnings per share for the quarter, beating the consensus estimate of -$1.2 by $0.26.
Is Acelrx Pharmaceuticals overvalued?
According to Wall Street analysts Acelrx Pharmaceuticals’s price is currently Overvalued.
Does Acelrx Pharmaceuticals pay dividends?
Acelrx Pharmaceuticals does not currently pay dividends.
What is Acelrx Pharmaceuticals’s EPS estimate?
Acelrx Pharmaceuticals’s EPS estimate is -$10.2.
How many shares outstanding does Acelrx Pharmaceuticals have?
Acelrx Pharmaceuticals has 8,198,110 shares outstanding.
What happened to Acelrx Pharmaceuticals’s price movement after its last earnings report?
Acelrx Pharmaceuticals reported an EPS of -$0.94 in its last earnings report, beating expectations of -$1.2. Following the earnings report the stock price went up 3.704%.
Which hedge fund is a major shareholder of Acelrx Pharmaceuticals?
Currently, no hedge funds are holding shares in ACRX
---
Acelrx Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
ACRX Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 4.7%
Last 30 Days ▲ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-88.45%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-33.15%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acelrx Pharmaceuticals
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
---
Top 5 ETFs holding ACRX
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ACRX. The ETFs are listed according to market value of ACRX within the ETF
---
---